REPLY
18.5.2021 09:32:11 CEST | Business Wire | Press release
Through its proprietary Trend Sonar trend monitoring platform, Reply recently conducted a study to examine how the e-commerce model has evolved over time – particularly in the automotive domain – revolutionising the sector and consequently influencing customer expectations.
A digital approach and a strong online presence have become indispensable in the automotive sector, especially since last year when the global pandemic placed the digital realm in a preferential lane, rewarding businesses that have been able to change their business model quickly in favour of digitisation.
Over the past year (more specifically from April 2020 to March 2021), analysing the frequency of mentions of millions of online sources – expert media articles, mass media, patents and scientific publications – Reply’s Trend Sonar monitoring platform has, indeed, confirmed a 61% growth in content related to automotive e-commerce compared to the previous 12 months.
An evolution that starts from afar. The automotive sector is not new to change: in the last 20 years it has been the protagonist of an unprecedented revolution. Reply’s analysis, in fact, shows that all the conditions and prerequisites are in place for the sector to find itself on the threshold of a new discontinuity.
The first online marketplaces for used cars date back to 2000, while a few years later the first online broker platforms began gaining popularity, directly connecting authorised dealers and end consumers and offering online booking, car configuration and digital brochure services. This was followed by the first online dealerships and, in recent years, car manufacturers have started selling their vehicles directly to the end consumer, adopting Direct to Consumer models.
Today's scenario: between the physical and the digital worlds. With the Covid-19 pandemic, the pace of digitalisation has greatly accelerated: digitised analytics systems, pricing tools and financing processes are now a necessary standard to help increase leads in the sector. Reply’s study highlights precisely how, at this point in time, we find ourselves at a crossroads between the offer of digital and traditional services. Indeed, in the near future, services such as 3D showrooms, virtual test drives, advanced configuration tools and digital concierge services are expected to see increasing use, allowing consumers to test and configure products directly online.
By opting for direct online sales to customers, native digital car manufacturers are turning the traditional car buying model upside down. The customer journey has also been impacted by the current revolution underway: leasing, financing, choice of insurance providers and coverage or even vehicle registration have recently digitised and automated the customer experience, shortening waiting times and eliminating paper documents.
The future of mobility is increasingly more virtual. Since car sharing services have entered the market, mobility has, in fact, begun to be perceived as a service built around the digital world . Many car manufacturers and industry suppliers are adopting an approach in which the car is becoming a platform capable of providing access to a broad digital ecosystem of app-based data and services. In fact, in the future, in addition to a means of mobility and transport, cars are expected to be increasingly used as a tool to collect data on customers. Access, exchange and sharing of this information will be decisive for defining future dynamics and for offering the customer a range of more complete and personalised services, which may even include solutions proposed by customers themselves.
More information on the research is available on Reply’s website at “E-commerce trends: mobility and car sales ”.
Reply
Reply [MTA, STAR: REY, ISIN: IT0005282865] specialises in the design and implementation of solutions based on new communication channels and digital media. As a network of highly specialised companies, Reply defines and develops business models enabled by the new models of AI, big data, cloud computing, digital media and the internet of things. Reply delivers consulting, system integration and digital services to organisations across the telecom and media; industry and services; banking and insurance; and public sectors. www.reply.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005081/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
First Plus Expands Relationship with SS&C to Support Cross-Border Operations in APAC3.8.2026 03:00:00 CEST | Press release
SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced that First Plus Asset Management (FPAM), a multi-asset investment management firm, has selected SS&C to provide cross-border operations support across Asia. SS&C will service First Plus across the full investment lifecycle, delivering a scalable, integrated solution supporting transfer agency, order management and execution and investment accounting. FPAM will utilize SS&C to service its growing cross-border operating model and support around $200 million in assets under management*. “As First Plus has expanded, managing our operations has become increasingly complex,” said Jeb Li, Co-Founder and CEO at First Plus. “SS&C’s global footprint and integrated offerings enable us to easily optimize our workflows, so we can focus on scaling quickly and securely while continuing to deliver risk-adjusted returns and best-in-class client service.” The engagement highlights the breadth and scalability of SS&C’s global service model.
Europe’s Largest Celebration of Irish Culture Arrives in Belfast2.8.2026 10:01:00 CEST | Press release
Fleadh Cheoil na hÉireann arrives in Belfast today (2 August), bringing eight days of traditional music, culture and celebration to the city, with organisers expecting up to 800,000 visitors over the course of the festival. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729147569/en/ Belfast Fleadh - Maddens Bar accordian, guitar and fiddle player (Chris Heaney) One of Europe’s largest cultural events, Fleadh Cheoil na hÉireann is taking place in Belfast for the first time, transforming the city into a vibrant stage for Irish music, dance, language and culture. More than 200 events and 180 traditional music competitions are taking place across venues, streets and neighbourhoods throughout the week-long celebration. The landmark festival showcases the very best of Irish culture, with a packed programme of All-Ireland competitions, concerts, community events and performances from both established and emerging artists. As Ir
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom